Ralliant (RAL) Competitors $48.19 +0.71 (+1.50%) As of 07/17/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock RAL vs. HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, FTV, and TERShould you be buying Ralliant stock or one of its competitors? The main competitors of Ralliant include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), and Teradyne (TER). These companies are all part of the "measuring and control equipment" industry. Ralliant vs. Its Competitors HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Fortive Teradyne HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Ralliant (NYSE:RAL) are both measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment. Is HTGMQ or RAL more profitable? Company Net Margins Return on Equity Return on Assets HTG Molecular DiagnosticsN/A N/A N/A Ralliant N/A N/A N/A Do analysts recommend HTGMQ or RAL? Ralliant has a consensus price target of $62.00, suggesting a potential upside of 28.66%. Given Ralliant's stronger consensus rating and higher probable upside, analysts plainly believe Ralliant is more favorable than HTG Molecular Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HTG Molecular Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ralliant 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media prefer HTGMQ or RAL? In the previous week, Ralliant had 13 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 13 mentions for Ralliant and 0 mentions for HTG Molecular Diagnostics. Ralliant's average media sentiment score of 0.79 beat HTG Molecular Diagnostics' score of 0.00 indicating that Ralliant is being referred to more favorably in the news media. Company Overall Sentiment HTG Molecular Diagnostics Neutral Ralliant Positive Which has preferable valuation & earnings, HTGMQ or RAL? Ralliant has lower revenue, but higher earnings than HTG Molecular Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/ARalliantN/AN/AN/AN/AN/A SummaryRalliant beats HTG Molecular Diagnostics on 5 of the 6 factors compared between the two stocks. Get Ralliant News Delivered to You Automatically Sign up to receive the latest news and ratings for RAL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RAL vs. The Competition Export to ExcelMetricRalliantIndustrial Measurement Instruments & Related Products IndustryManufacturing SectorNYSE ExchangeMarket Cap$5.36B$5.36B$2.18B$20.75BDividend YieldN/AN/A2.60%3.67%P/E RatioN/AN/A22.2027.60Price / SalesN/AN/A106.8259.14Price / CashN/AN/A13.4022.13Price / BookN/AN/A75.834.66Net IncomeN/AN/A-$127.36M$994.58M7 Day PerformanceN/AN/A0.96%0.00%1 Month PerformanceN/AN/A2.06%5.25%1 Year PerformanceN/AN/A21.39%10.76% Ralliant Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RALRalliantN/A$48.19+1.5%$62.00+28.7%N/A$5.36BN/A0.007,000News CoverageAnalyst ForecastAnalyst RevisionHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.06-16.4%N/A-62.3%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.03-11.0%N/A+243.9%$0.00$41.52M0.001Positive NewsGap DownQSIAWQuantum-SiN/A$0.62+6.0%N/A+221.1%$0.00$3.44M0.00150Positive NewsGap UpSMAPWSportsMap Tech AcquisitionN/A$0.03-8.5%N/AN/A$0.00N/A0.00N/AGap DownTTTrane Technologies4.436 of 5 stars$437.39+0.7%$434.00-0.8%+34.1%$97.57B$20.31B36.3945,000Positive NewsAnalyst ForecastKEYSKeysight Technologies4.1454 of 5 stars$163.70-0.7%$183.00+11.8%+12.0%$28.17B$4.98B38.4315,500Positive NewsAnalyst ForecastVLTOVeralto2.9497 of 5 stars$101.89-1.2%$110.09+8.0%+5.0%$25.26B$5.28B29.1117,000Positive NewsFTVFortive4.964 of 5 stars$52.66-0.8%$73.67+39.9%-34.2%$17.91B$6.23B23.1018,000Analyst DowngradeTERTeradyne4.8629 of 5 stars$97.05-1.6%$112.50+15.9%-39.1%$15.57B$2.82B27.426,500Analyst Downgrade Related Companies and Tools Related Companies HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives VLTO Alternatives FTV Alternatives TER Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RAL) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ralliant Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ralliant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
